March 2012
Oncology Clinical Trials — Secrets of Success

BROUGHT TO YOU BY

Data shows that drugs in development for oncology indications had the lowest overall clinical trial success rate of all therapeutic areas in development since 2004. Are biomarkers the answer? Learn more

Share:

FOOD & AGRICULTURE

Greenpeace Founder: Support Biotech Crops
During a keynote address at the Manitoba Special Crops Symposium, Dr. Patrick Moore, a co-founder of Greenpeace, called opposition to GM rice with beta carotene a crime against humanity. Read more

Share:

BIO INTERNATIONAL CONVENTION

2012 BIO International Convention: Programming Update
With Convention less than four months away, things are quickly falling in to place with several programming updates to note! Read more

Share:

INDUSTRIAL & ENVIRONMENTAL

Presidential Memo: Purchase Biobased Products
President Obama issued a Presidential Memorandum that challenges the federal government to substantially increase purchases of biobased products over the next two years, driving new job growth and innovation. Read more

Share:

JIM'S CORNER

FAST Act
Representatives Cliff Stearns (R-FL) and Ed Towns (D-NY) introduced the Faster Access to Specialized Treatments (FAST) Act earlier this month.It would speed access to innovative new therapies and cures to patients living with debilitating and life-threatening diseases. Read more

Share:

HEALTH CARE

Take the PKD Foundation Challenge
In this podcast, Gary Godsey, President and CEO of the PKD Foundation, encourages listeners to take the 31 Day PKD Challenge as part of National Kidney Month. Read more

Share:

BUSINESS OF BIOTECH

Emerging Companies
William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Read more

Share:

*Share BIOtechNOW* E-Newsletter on:**					Visit:

PERSPECTIVE
Reauthorizing PAHPA
Senator Robert P. Casey, Jr. (D-PA) explains why reauthorizing the Pandemic All-Hazards Preparedness Act is critical.
Read more

EVENTS

IP Counsels Committee Conference
April 16–April 18, 2012
Austin, Texas

World Congress
April 29–May, 2 2012
Orlando, Florida

BIO International Convention
June 18–June 21, 2012
Boston, Massachusetts

RECENT PODCASTS

Bob Coughlin of MassBio discusses the elements of a supportive bioscience industry climate and looks ahead to the 2012 BIO International Convention.

Ron Cohen, President and CEO of Acorda Therapeutics, discusses how the federal government can best support innovation within the biotechnology industry